Core Laboratories NV (NYSE:CLB) shares were up 2.8% on Thursday . The stock traded as high as $125.43 and last traded at $125.04, with a volume of 220,919 shares. The stock had previously closed at $121.64.

Several research analysts have recently weighed in on CLB shares. Citigroup Inc. boosted their target price on Core Laboratories NV from $115.00 to $123.00 and gave the stock a “neutral” rating in a report on Monday, May 16th. Stephens started coverage on Core Laboratories NV in a report on Tuesday, April 5th. They set an “equal weight” rating and a $89.00 target price on the stock. Zacks Investment Research upgraded Core Laboratories NV from a “sell” rating to a “hold” rating in a report on Monday, May 16th. Cowen and Company restated a “hold” rating on shares of Core Laboratories NV in a report on Saturday, April 23rd. Finally, Royal Bank Of Canada boosted their target price on Core Laboratories NV from $128.00 to $137.00 and gave the stock an “outperform” rating in a report on Friday, April 22nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $119.94.

The company has a 50-day moving average price of $123.07 and a 200 day moving average price of $112.92. The stock has a market capitalization of $5.25 billion and a PE ratio of 53.56.

Core Laboratories NV (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 20th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.37. The firm had revenue of $153.65 million for the quarter, compared to analysts’ expectations of $161.24 million. During the same period last year, the firm earned $0.86 EPS. The business’s quarterly revenue was down 28.1% on a year-over-year basis. Analysts expect that Core Laboratories NV will post $1.61 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Monday, July 18th will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Thursday, July 14th.

A number of large investors have recently added to or reduced their stakes in CLB. Comerica Bank increased its stake in Core Laboratories NV by 1.0% in the fourth quarter. Comerica Bank now owns 23,101 shares of the company’s stock valued at $2,246,000 after buying an additional 239 shares during the period. Swiss National Bank increased its stake in Core Laboratories NV by 1.2% in the fourth quarter. Swiss National Bank now owns 77,200 shares of the company’s stock valued at $8,395,000 after buying an additional 900 shares during the period. Howland Capital Management LLC increased its stake in Core Laboratories NV by 4.7% in the fourth quarter. Howland Capital Management LLC now owns 102,070 shares of the company’s stock valued at $11,099,000 after buying an additional 4,562 shares during the period. Ameritas Investment Partners Inc. purchased a new stake in Core Laboratories NV during the fourth quarter valued at about $1,043,000. Finally, Sawtooth Asset Management Inc. increased its stake in Core Laboratories NV by 992.9% in the fourth quarter. Sawtooth Asset Management Inc. now owns 17,923 shares of the company’s stock valued at $1,949,000 after buying an additional 16,283 shares during the period.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.